Throughout 2020, Blue Health Intelligence® (BHI®) used its access to more than 20 billion claims from over 200 million unique members to examine healthcare trends affecting the health of millions of Americans. This digest contains five studies on the following topics: COVID-19, men’s health, UV safety, HPV vaccinations, and childhood obesity.
This brief examines COVID-19’s impact on preventive services and telehealth using national claims data from 2019 and 2020. The descriptive studies of preventive service episodes included doctor visits and related preventive screenings such as mammograms, pap smears, and colonoscopies. The study also looks at differences in the use of preventive services and telehealth between urban and rural areas.
Blue Health Intelligence® (BHI®) examined breast cancer rates in women between 40 and 64 years of age using national commercial claims data from 2016 through 2019. The study looked at costs and trends over the four years with a brief look into how the pandemic affected breast cancer screening and diagnostic mammograms utilization in 2020.
In this report, Blue Health Intelligence® (BHI®) presents a summary of recent healthcare trends using claims data from the most trusted commercial health plans. In looking across all this information, three trends continue to rise to the surface: Cost increases are outpacing healthcare utilization. Care settings continue to have a huge impact on costs. The prescription drug cost gap is still …
In this Health of America report, the Blue Cross Blue Shield Association, in collaboration with Blue Health Intelligence, examines the role that caregivers play an important role in the U.S. healthcare system. The commitment of time, labor and emotional support this role requires can have a substantial impact on caregivers’ physical, behavioral and emotional well-being.
In this Health of America report, the Blue Cross Blue Shield(BCBS) Association, in collaboration with Blue Health Intelligence, examines the rate of colorectal cancer diagnoses and preventive screenings, as well as the reasons why two of the most at-risk populations of commercially insured Americans say they avoid or delay screening.
The Episode of Care (EoC) Grouper from Blue Health Intelligence® (BHI®) is the leading edge of commercial groupers, unique in its inclusion of both procedures and conditions, and in its fully transparent methodology. This white paper discusses how the BHI EoC Grouper’s ability to provide a high-level conceptual model of illness, diagnosis, and treatment of individual patients for specified conditions …
Research from Blue Health Intelligence® (BHI®) found that trends in obesity increased in both adults and children from 2016 to 2019. Children ages 2-4 showed the highest annual increase (20.6%). Childhood obesity puts children at increased risk of disease, and these health risks can continue into adulthood.
Blue Health Intelligence® (BHI®) examined claims data for females and males who were continuously enrolled in a commercial health insurance plan and found the rate of HPV vaccination increased 5.9 percentage points for females and 7.8 percentage points for males in four years (2016 and 2019.)
Research from Blue Health Intelligence® (BHI®) found that skin cancer and melanoma rates differed widely from state to state. This brief examines the rate of skin cancer and melanoma occurrence across the U.S. in 2019.